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Abstract 
Introduction: The Helicobacter pylori (HP) reinfection rate seems to be higher in developing countries than in developed ones. An increased 
seroprevalence of HP has also been reported in patients with type 1 diabetes (T1D) and Hashimoto’s thyroiditis (HT). Mycobacterium avium 
subsp. paratuberculosis (MAP) has been linked to both T1D and HT. Quite a few lines of evidence indicate that autoantibodies against 
several epitopes belonging to human zinc transporter 8 (ZnT8) cross-recognize the homologous MAP3865c epitopes in both T1D and HT 
patients. HP may play a role in HT disease, most likely acting through a molecular mimicry mechanism that targets ZnT8 as reported for 
MAP and the two autoimmune diseases. 
Methodology: An enzyme-linked immunosorbent assay (ELISA) has been developed for the detection of antibodies against several epitopes 
deriving from HP proteins, which are highly homologous to the immunodominant ZnT8 peptides previously identified: ZnT8178–186 and 
ZnT8186–194. 
Results: None of the HP peptides tested were significantly recognized when the humoral responses of 92 HT patients and 91 healthy 
volunteers were analyzed. 
Conclusions: These findings do not support a triggering role for HP (through ZnT8 mimicking) in HT. If a molecular mimicry phenomenon 
is taking place, it involves a different self-antigen. Moreover, the negative outcome of the experiments performed stresses the fact that 
sharing stretches of sequence homology is relevant, but not enough to trigger an antibody-mediated cross-recognition. 
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Introduction 
Autoimmune diseases, such as Hashimoto’s 
thyroiditis (HT) and type 1 diabetes (T1D), stem from 
the interaction of genetic susceptibility and 
environmental exposures [1-4]. A distinctive marker 
of HT is the presence of autoantibodies (aAbs) against 
thyroglobulin (Tg), thyroperoxidase (TPO), and 
thyrotropin receptor (TR) [5]. Infectious agents such 
as bacteria and viruses may trigger autoimmunity 
[6,7] through a molecular mimicry mechanism, being 
able to mimic the antigenic profile of the epithelial cell 
lining the thyroid gland. Among the environmental 
factors activated is Helicobacter pylori (HP), a chronic 
pathogen living in the human stomach, which typically 
colonizes and infects the gastric mucosa. This Gram-
negative bacterium is responsible for gastritis, which 
can progress to gastric/duodenal ulcers and 
carcinomas. 
The overall prevalence of HP infection is higher in 
developing countries compared to developed nations 
[8]. 
Contradictory conclusions have been reported for 
HP infection and HT disease, both confirming and 
denying the existence of an association [9,10].  
What is more, the existence of a remarkable 
correlation between Mycobacterium avium subsp. 
paratuberculosis (MAP) infection/seroprevalence and 
autoimmune diseases such as T1D and HT was 
recently demonstrated [1]. Researchers found a very 
strong humoral response mounted against epitopes 
belonging to one MAP membrane protein 
(MAP3865c), and against the homologous region 
present in human ZnT8, which is a relevant T1D 
autoantigen specifically expressed in the pancreatic β-
cell and in the cubical epithelium that lines thyroid 
follicles [1-3]. 
The reported increased prevalence of anti-
MAP3865c and anti-ZnT8 antibodies (Abs) in 
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Sardinian T1D and HT subjects indicates that MAP is 
a possible environmental trigger of both autoimmune 
diseases. MAP and HP may express proteins capable 
of mimicking self-antigens through a common 
mechanism, leading to the production of aAbs, which 
in turn may cause self-aggression. 
To determine if this was true, and to identify in 
human ZnT8 the most likely common target for 
molecular mimicry in both HT and T1D, we 
investigated the prevalence anti-HP Abs developed 
against four HP peptides highly homologous to ZnT8 
immunodominant (ZnT8178–186 and ZnT8186–194) 
epitopes in a Sardinian population cohort of 92 HT 




A group of 92 HT patients (female : male ratio, 
10.75 : 1; mean age, 47 ± 13 years) followed at the 
University Hospital of Sassari, Department of 
Endocrinology, and a control group consisting of 91 
age and sex-matched healthy individuals were enrolled 
in the study. All the subjects were inhabitants of 
Sardinia, Italy. All healthy controls (HCs) had not 
undergone therapy for at least six months and had no 
history of autoimmune diseases or clinically 
inflammatory diseases. All study subjects provided 
signed informed consent prior to the sample and data 
collection, and the study protocol was approved by the 
University Hospital of Sassari, Italy. 
 
Peptides 
Four HP peptides highly homologous to human 
ZnT8178–186 and ZnT8186–194 were assayed in this study: 
J0I929_HELPX1-11 [MIIGGGVSGCA] derived from 
HP quinone oxidoreductase J0I929_HELPX protein 
(UniProtKB accession number: J0I929); 
J0T7E7_HELPX40-47 [IIINSCTV] derived from HP 
Radical SAM methylthiotransferase, MiaB/RimO 
family protein J0T7E7_HELPX protein 
(UniProtKB: accession number J0T7E7); 
T2S9C8_HELPX76-82 [VAQNIVL] derived from HP 
T2S9C8_HELPX hipothetical protein 
(UniProtKB: accession number T2S9C8); 
T2T4W3_HELPX99-105 [AGIVLTV] derived from HP 
Preprotein translocase subunit T2T4W3_HELPX 
(UniProtKB: accession number T2T4W3). All 
peptides were synthesized at > 90% purity 
commercially (LifeTein, South Plainfield, USA). 
Purified peptides were stocked as 10 mM solutions 
and stored in single-use aliquots at -80°C.  
 
Enzyme-linked immunosorbent assay (ELISA) 
Indirect ELISAs were performed in order to verify 
the humoral response mounted against the selected 
peptides as previously described [3]. Briefly, ELISA 
96-well Nunc immunoplates were coated with 10 
μg/mL of peptides diluted in 0.05 Μ carbonate-
bicarbonate buffer, pH 9.5 (Sigma, St. Louis, USA) 
overnight at 4°C. The remaining protein-free sites in 
the plate were blocked by 200 μL/well of 5% 
phosphate-buffered saline (PBS)-non-fat dried milk 
(Sigma, St. Louis, USA) solution upon incubation for 
two hours at room temperature. After being washed 
twice with PBS containing 0.05% Tween-20 (PBS-T), 
serum samples at 1:100 dilution in 0.05% PBS-T were 
added and incubated for two hours at room 
temperature. Extensive washing of the plate was 
followed by addition of 100 μL of goat anti-human 
immunoglobulin G polyclonal Ab (1:1000; Sigma, St. 
Louis, USA) and incubation for one hour at room 
temperature. Finally, after five washes in PBS-T, the 
reaction was developed by adding 100 μL/well of para 
nitrophenylphosphate (Sigma, St. Louis, USA) as 
substrate for alkaline phosphatase. Plates were 
incubated in the dark for about 10 minutes, and optical 
density (OD) was measured at 405 nm using 
aVERSATunable Max microplate reader (Molecular 
Devices, Orleans Drive Sunnyvale, USA). Negative 
and positive control wells were included in each plate 
tested, and results are expressed as means of three 
different experiments performed. 
 
Statistical analysis 
Statistical analyses were performed using 
GraphPad 6 Software. Data was presented as mean ± 
standard error or median (25th and 75th percentiles) as 
clinical and laboratory data for each parameter 
analyzed. The results were analyzed by Fisher's exact 
test, and p ≤ 0.05 was considered to be significant. The 
cut-off values were determined by receiver operating 
characteristic (ROC) curve analyses using values 
normalized to a strongly positive control included in 
each essay performed. The specificity was set at > 




BLAST analysis showed that J0T7E7_HELPX40-47 
and J0I929_HELPX1-11 were homologous to human 
ZnT8178–186 peptide, whereas T2S9C8_HELPX76-82 and 
T2T4W3_HELPX99-105 were homologous to human 
ZnT8186–194 peptides. Both human peptides, which 
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derive from zinc transporter 8 protein, are known to be 
linked to HT and T1D [1-3].  
J0T7E7_HELPX40-47 was recognized by 7.6% of 
the HT patients and by 6.6% of HCs (area under the 
curve [AUC] = 0.5; p = 0.5), and J0I929_HELPX1-11 
was recognized by 15.2% of the HT patients and by 
6.6% of HCs (AUC = 0.54; p = 0.16).  
Regarding the peptides homologous to ZnT8186–194, 
T2S9C8_HELPX76-82 was recognized by 16.4% of the 
HT patients and by 6.6% of HCs (AUC = 0.54; p = 
0.07), while T2T4W3_HELPX99-105 was recognized by 
12% of the HT patients and by 6.6% of HCs (AUC = 
0.58, p = 0.46).  
As shown in Figure 1, all selected peptides 
displayed the same Ab reactivity in the HCs group and 
very similar percent fraction of Ab-positivity in the 
HT one; in any case, there was no statistically 
significant difference between patients and controls. 
 
Discussion 
We investigated whether HP might play a role in 
HT disease, probably acting through a molecular 
mimicry mechanism which targets human ZnT8 
protein as it was reported for MAP [1-3]. We aimed to 
find an explanation accounting for the interconnection 
found between HP infection and two autoimmune 
diseases, HT and T1D [11], which have been proven 
to be associated with MAP infection [1-3]. 
To achieve this goal, we searched for Abs against 
four HP peptides (Table 1), which are highly 
homologous to two human ZnT8 immunodominant 
epitopes, ZnT8178–186 and ZnT8186–194, the latter being 
highly recognized by the sera of HT and T1D subjects 
[1-3].  
Our group recently demonstrated that Abs 
recognizing epitopes belonging to MAP3865c protein 
(MAP3865c125–133 and MAP3865c133–141) cross-react 
with ZnT8 homologous ones (ZnT8178–186 and ZnT8186–
194), mounting a molecular mimicry mechanism which 
may be in turn responsible for self-aggression [1-3].  
Therefore, we postulated that MAP and HP may 
express proteins capable of mimicking the same self-
antigens ZnT8. Nevertheless, this study failed to find a 
direct association between HP seropositivity and HT. 
Indeed, there was no statistically significant difference 
in the seroprevalence of HP infection in Sardinian HT 
patients compared to control participants, which were 
matched for age, sex, and socioeconomic status. 
Accordingly, we concluded that these HP epitopes 
are not correlated with HT. If a molecular mimicry 
phenomenon is taking place, it certainly targets 
Table 1. Alignment of the amino acid sequences of the identified peptides by ClustalW2. 
Peptide name Sequence alignment Protein 
ZnT8178–186 MII---VSSCAV Human zinc transporter 8 
HPM5_03281-11 MIIGGGVSGCA- Helicobacter pylori HPM5_0328 
ZnT8178–186 MIIVSSCAV Human zinc transporter 8 
HPM3_049640-47 -IIINSCTV Helicobacter pylori HPHPM3_0496 
ZnT8186–194 VAANIVLTV Human zinc transporter 8 
HPSA50_163576-82 VAQNIVL-- Helicobacter pylori HPSA50_1635 
ZnT8186–194 VAANIVLTV Human zinc transporter 8 
SecD99-105 --AGIVLTV Helicobacter pylori SecD 
Result shows fully conserved residue (*), strongly similar properties (:), weakly similar properties (.) and missing regions (-). 
Figure 1. Dot plot showing the distribution of IgG for the four 
Helicobacter pylori (HP) peptides measured by indirect ELISA 
A total of 91 HT patients and 91 healthy controls were screened for 
IgG antibodies against J0T7E7_HELPX40-47 (A) and J0I929_HELPX1-11 
(B) homologous to ZnT8178–186, and against T2S9C8_HELPX76-82 (C) 
and T2T4W3_HELPX99-105 (D) homologous to ZnT8186–194. The black 
bars represent the median with interquartile range. The dotted lines 
indicate the respective cut-off values calculated by ROC analysis and 
used as threshold in discriminating between positive and negative sera. 
Area under roc curve (AUC) and p values are displayed in the right 
corner. Each experiment was independently repeated at least three 
times. 
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different self-antigens. What is more, the negative 
outcome of the experiments performed stresses the 
fact that sharing stretches of sequence homology is 
relevant, but not enough to trigger an antibody-
mediated cross-recognition. 
Conclusions 
These findings do not support a triggering role for 
HP (through ZnT8 mimicking) in HT disease. Indeed, 
we cannot discount a direct involvement of HP in HT, 
which might act as an environmental trigger, targeting 
different self-antigens via molecular mimicry. To 
verify this hypothesis, further studies should seek and 
identify new possible sources of cross-reactive Abs; 
moreover, the genetic polymorphism of the host needs 
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